Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin A Hodgkinson

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Research Square|January 9, 2026
Recurrent & non-recurrent copy number variants in Native Americans and a cosmopolitan sample in relation to Alcohol Use Disorder and other psychiatric diseasesSalma M Wakil, Keita Morisaki, Pei-Hong Shen, et al.
The International Journal of Neuropsychopharmacology|May 21, 2013
DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorderJonathan Savitz, Colin A Hodgkinson, Chantal Martin-Soelch, et al.
Molecular Neurobiology|March 23, 2026
Recurrent and Non-Recurrent Copy Number Variants in Native Americans and a Cosmopolitan Sample in Relation to Alcohol Use Disorder and Other Psychiatric DiseasesSalma M Wakil, Keita Morisaki, Pei-Hong Shen, et al.
Developmental Psychobiology|August 3, 2019
Relations between catechol-O-methyltransferase Val158Met genotype and inhibitory control development in childhoodMaureen E Bowers, George A Buzzell, Virginia Salo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 30, 2019
Epigenetic aging is accelerated in alcohol use disorder and regulated by genetic variation in APOL2Audrey Luo, Jeesun Jung, Martha Longley, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2010
A genetically modulated, intrinsic cingulate circuit supports human nicotine addictionL Elliot Hong, Colin A Hodgkinson, Yihong Yang, et al.
Alcoholism, Clinical and Experimental Research|November 19, 2010
Haplotype-based study of the association of alcohol-metabolizing genes with alcohol dependence in four independent populationsJixia Liu, Zhifeng Zhou, Colin A Hodgkinson, et al.
Alcoholism, Clinical and Experimental Research|May 17, 2008
Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trialStephanie S O'Malley, Robert W Robin, Aryeh L Levenson, et al.
Psychiatric Genetics|January 2, 2013
A large-scale candidate gene analysis of mood disorders: evidence of neurotrophic tyrosine kinase receptor and opioid receptor signaling dysfunctionAnthony J Deo, Yung-yu Huang, Colin A Hodgkinson, et al.
Alcoholism, Clinical and Experimental Research|May 7, 2014
Differential impact of serotonin transporter activity on temperament and behavior in persons with a family history of alcoholism in the Oklahoma Family Health Patterns ProjectWilliam R Lovallo, Mary-Anne Enoch, Eldad Yechiam, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Research Square|January 9, 2026
Recurrent & non-recurrent copy number variants in Native Americans and a cosmopolitan sample in relation to Alcohol Use Disorder and other psychiatric diseasesSalma M Wakil, Keita Morisaki, Pei-Hong Shen, et al.
The International Journal of Neuropsychopharmacology|May 21, 2013
DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorderJonathan Savitz, Colin A Hodgkinson, Chantal Martin-Soelch, et al.
Molecular Neurobiology|March 23, 2026
Recurrent and Non-Recurrent Copy Number Variants in Native Americans and a Cosmopolitan Sample in Relation to Alcohol Use Disorder and Other Psychiatric DiseasesSalma M Wakil, Keita Morisaki, Pei-Hong Shen, et al.
Developmental Psychobiology|August 3, 2019
Relations between catechol-O-methyltransferase Val158Met genotype and inhibitory control development in childhoodMaureen E Bowers, George A Buzzell, Virginia Salo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 30, 2019
Epigenetic aging is accelerated in alcohol use disorder and regulated by genetic variation in APOL2Audrey Luo, Jeesun Jung, Martha Longley, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2010
A genetically modulated, intrinsic cingulate circuit supports human nicotine addictionL Elliot Hong, Colin A Hodgkinson, Yihong Yang, et al.
Alcoholism, Clinical and Experimental Research|November 19, 2010
Haplotype-based study of the association of alcohol-metabolizing genes with alcohol dependence in four independent populationsJixia Liu, Zhifeng Zhou, Colin A Hodgkinson, et al.
Alcoholism, Clinical and Experimental Research|May 17, 2008
Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trialStephanie S O'Malley, Robert W Robin, Aryeh L Levenson, et al.
Psychiatric Genetics|January 2, 2013
A large-scale candidate gene analysis of mood disorders: evidence of neurotrophic tyrosine kinase receptor and opioid receptor signaling dysfunctionAnthony J Deo, Yung-yu Huang, Colin A Hodgkinson, et al.
Alcoholism, Clinical and Experimental Research|May 7, 2014
Differential impact of serotonin transporter activity on temperament and behavior in persons with a family history of alcoholism in the Oklahoma Family Health Patterns ProjectWilliam R Lovallo, Mary-Anne Enoch, Eldad Yechiam, et al.
Pageof 9